G R Armitage

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

D. Osoba, I. Tannock, M. Stockler, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.

B. Zee, N. Iscoe, I. Quirt, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group.

N. Boyd, J. Ragaz, M. Knowling, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.